The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of tumor recurrence after hepatectomy remains high. Tumor recurrence can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Several tumor f...
Saved in:
| Main Authors: | Liang-He Yu, Nan Li, Shu-Qun Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.4061/2011/416459 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
by: Han-Yue Mo, et al.
Published: (2016-01-01) -
Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Peng Yuan, et al.
Published: (2016-01-01) -
Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
by: Kang Wang, et al.
Published: (2015-01-01) -
Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01) -
Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma
by: Jingzhu Lv, et al.
Published: (2017-01-01)